Successful evaluation of the BÜHLMANN fPELA® turbo test at Bioanalytica in Lucerne - Interview with Yvonne Schallberger about the successful evaluation of the BÜHLMANN fPELA® turbo test at Bioanalytica in Lucerne.
The latest BÜHLMANN poster about Therapeutic Drug Monitoring at the United European Gastroenterology Week 2021 - Quantum Blue® Infliximab and Quantum Blue® Adalimumab offer quantification of infliximab and adalimumab originator drugs, as well as their biosimilars, allowing for identification of patients with suboptimal drug levels as part of their therapeutic drug monitoring.
Omicron Stealth (BA.2) – Seegene lauches new SARS-COV-2 Variant Assay - We are happy to announce the new Novaplex™ SARS-CoV-2 Variant VII Assay from Seegene, which will become available by the end of December 2021.

Assises Nationales des MICI 2022

Date: 21 January 2022
Location: Paris, France

15e Assises Nationales des MICI

ECCO 2022

Date: 16 – 19 February 2022
Location: Vienna, Austria

Inflammatory Bowel Diseases – 17th Congress of ECCO. Visit our booth #23

BBDT 2022

Date: 12 March 2022
Location: Potsdam, Germany

Berlin Brandenburger Darmtag

POCT 2022

Date: 15 – 17 March 2022
Location: Munich, Germany

5. Münchner Point-of-Care Testing Symposium